Quantcast
Last updated on April 21, 2014 at 1:20 EDT

Latest Boston Scientific Corporation Stories

2014-04-17 08:29:03

Event Will Be Held in San Francisco, Site of the Heart Rhythm Society 35th Annual Scientific Sessions NATICK, Mass., April 17, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will host an investor event on May 8, 2014 to provide an update on company Cardiac Rhythm Management and Electrophysiology initiatives as well as developments and technologies in connection with its attendance at the 2014 Annual Heart Rhythm Society Scientific Session in San Francisco, CA. The...

2014-04-15 16:28:34

NATICK, Mass., April 15, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has received FDA approval for its latest generation of defibrillators and heart failure devices designed to advance patient care. The newly approved devices include the DYNAGEN(TM) MINI and INOGEN(TM) MINI ICDs, as well as the DYNAGEN(TM) X4 and INOGEN(TM) X4 CRT-Ds. The X4 line of quadripolar CRT-Ds offers 70 percent more pacing options to address high capture thresholds and phrenic nerve...

2014-04-02 00:23:28

These and Other Studies Reinforce Global Commitment to the Development of Innovative Therapies to Improve Care for Patients with Cardiovascular Disease NATICK, Mass., April 1, 2014 /PRNewswire/ -- Reinforcing its position as a global leader in bringing new therapies to patients with heart and cardiovascular disease, Boston Scientific Corporation (NYSE: BSX) reported favorable results in studies related to cardiac resynchronization therapy (CRT), platinum chromium stent platforms and...

2014-04-01 16:25:47

NATICK, Mass., April 1, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the first quarter ended March 31, 2014 on Tuesday, April 29, 2014 at 8:00 a.m. ET. The call will be hosted by Mike Mahoney, president and chief executive officer, and Dan Brennan, executive vice president and chief financial officer. A live webcast of the conference call will be available via Boston Scientific's website. Webcast...

2014-04-01 12:32:58

LONDON, April 1, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:MediPoint: Cardiac Rhythm Management - Global Analysis and Market ForecastsMediPoint: Cardiac Rhythm Management - Global Analysis and Market ForecastsSummaryCardiac rhythm management (CRM) comprises any method of treatment aimed at regulating the heart's rhythm, including medication, medical devices, and occasionally surgery. There can be a number of reasons why CRM is needed, all of...

2014-04-01 08:29:30

Interim results of the EFFORTLESS registry published in the European Heart Journal NATICK, Mass., April 1, 2014 /PRNewswire/ -- Real-world data on the Boston Scientific Corporation (NYSE:BSX) S-ICD System (Subcutaneous Implantable Defibrillator) are highlighted online this week in the European Heart Journal. The interim analysis of the ongoing EFFORTLESS S-ICD registry, which evaluated 456 patients with a mean follow-up of 558 days, is the first real world study to date and confirms the...

2014-03-30 12:20:07

MADIT-CRT Long-Term Follow-up Results Presented at the American College of Cardiology and Published in the New England Journal of Medicine NATICK, Mass., March 30, 2014 /PRNewswire/ -- In the longest follow-up to date of cardiac resynchronization therapy (CRT) for mild heart failure patients, Boston Scientific Corporation's (NYSE: BSX) exclusively sponsored and landmark Multicenter Automatic Defibrillator Implantation Trial - Cardiac Resynchronization Therapy (MADIT-CRT) study...

2014-03-27 08:35:15

Includes Late Breaking Clinical Trial Assessing Use of the Boston Scientific CRT-D Therapyin Patients with Mild Heart Failure NATICK, Mass., March 27, 2014 /PRNewswire/ -- At the 63(rd) Annual Scientific Session of the American College of Cardiology (ACC), March 29 - 31 in Washington, D.C., Boston Scientific Corporation (NYSE: BSX) will reinforce its commitment to research and development of innovative technologies to address global challenges in treating cardiovascular disease. According to...

2014-03-19 16:23:53

NATICK, Mass., March 19, 2014 /PRNewswire/ -- Boston Scientific has received a Shingo award from the Shingo Institute, part of the Jon M. Huntsman School of Business at Utah State University, in recognition for delivering world class results and demonstrating an ongoing commitment to leading and influencing a strong culture of operational excellence at its Maple Grove, Minn. manufacturing facility. "Receipt of the Shingo Silver Medallion signifies an organization's strong use of...

2014-03-14 12:28:23

First implant took place in France, at the Nouvelles Cliniques Nantaises in Nantes NATICK, Massachusetts, March 14, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announces CE Mark approval and European market launch of the INGEVITY(TM) family of magnetic resonance imaging (MRI) compatible pacing leads. Pacing leads are insulated wires that connect an implantable pacemaker to the heart for treatment of bradycardia, a condition in which the heart beats too...